A Clinical Trail of Iodine[131I] Metuximab Injection With CIK Cells for Preventing Hepatocellular Carcinoma

NCT01758679 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Multiple Drug Use

Interventions

BIOLOGICAL: Licartin and CIK

Sponsor

Tianjin Medical University Cancer Institute and Hospital